ARTICLE | Company News
Biomax, Molecular Networks GmbH deal
July 23, 2001 7:00 AM UTC
The companies will develop software tools for optimized drug target lead generation and validation. The deal combines Biomax's technology in DNA and protein sequence analysis with Molecular Networks' ...